EUCR

Eucrates Biomedical Acquisition

EUCR | NASDAQ
Chart Builder DCF Calculator
$10.04
$0.00 (0.00%)
At close: Apr 26, 2023, 03:14 PM ET
+0.00%

Rating

Updated: Sep 25, 2026
16.5
Fundamentals Weak
Market Sentiment Neutral
Moat None

Key Statistics

Market Data

Market Cap $42.23M
1D Range
10.02 10.04
52W Range
9.87 10.25

Valuation (TTM)

PE 18.25
PB 4.95
EV/EBITDA -115.44

Valuation (NTM)

Forward PE N/A
Forward PEG -0.13
Price Target N/A
Loading financial charts...

Profile

Eucrates Biomedical Acquisition Corp. currently lacks substantial business operations. Its primary objective is to execute a corporate transaction such as a merger, stock swap, asset purchase, equity ...

Employees n/a
IPO Date Dec 28, 2020
Website n/a
Fiscal Year January - December

Latest News

No news articles available yet.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.